Citigroup
DSCI

Citigroup’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Citigroup’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15
Closed – – 7573
2016
Q4 		$0 Hold
15
– – ﹤0.01% 7544
2016
Q3 		$0 Hold
15
– – ﹤0.01% 7437
2016
Q2 		$0 Sell
15
-710
-98% -$2.65K ﹤0.01% 7954
2016
Q1 		$2K Sell
725
-1,100
-60% -$3.69K ﹤0.01% 7259
2015
Q4 		$8K Sell
1,825
-3,985
-69% -$18.9K ﹤0.01% 6914
2015
Q3 		$27K Hold
5,810
– – ﹤0.01% 5839
2015
Q2 		$42K Sell
5,810
-343
-6% -$2.58K ﹤0.01% 5660
2015
Q1 		$52K Sell
6,153
-2,632
-30% -$22.4K ﹤0.01% 5520
2014
Q4 		$82K Buy
8,785
+4,181
+91% +$36.3K ﹤0.01% 5385
2014
Q3 		$38K Buy
4,604
+870
+23% +$8.06K ﹤0.01% 5499
2014
Q2 		$43K Sell
3,734
-13,015
-78% -$134K ﹤0.01% 5271
2014
Q1 		$212K Buy
16,749
+7,997
+91% +$103K ﹤0.01% 4275
2013
Q4 		$94K Buy
8,752
+4,361
+99% +$50.7K ﹤0.01% 5306
2013
Q3 		$55K Sell
4,391
-1,925
-30% -$26.6K ﹤0.01% 5227
2013
Q2 		$85K Buy
+6,316
New +$81.2K ﹤0.01% 4995

Other funds holding DSCI

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Citigroup's DSCI Position: Q1 2017 in Review

Citigroup sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 15 shares.

Citigroup first reported a position in DSCI in Q2 2013 and held it in 15 quarters. The position peaked at $212K in Q1 2014. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

  • Citigroup reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
  • Citigroup sold 15 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017.
  • Citigroup first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 15 quarters.
  • Citigroup's Derma Sciences, Inc. Common Stock (DE) position peaked at $212K in Q1 2014.
  • 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.